Recovery of resistance factors from a drug-free community
Gardner, P.; Smith, D.H.; Beer, H.; Moellering, R.
Lancet 1(7641): 301
1970
ISSN/ISBN: 0140-6736 PMID: 4189319 Document Number: 23020
Document emailed within 1 workday
Related Documents
Saprin, A.N.; Kalinina, E.V.; Serezhenkov, V.A.; Kotova, I.N.; Solomka, V.S.; Shcherbak, N.P. 2006: Changes in the free-radical state and level of free iron during the formation of drug resistance in tumor cells Biofizika 51(3): 485-490Yamamoto, T.; Nishiyama, A.; Takano, T.; Yabe, S.; Higuchi, W.; Razvina, O.; Shi, D. 2010: Community-acquired methicillin-resistant Staphylococcus aureus: community transmission, pathogenesis, and drug resistance Journal of Infection and Chemotherapy: Official Journal of the Japan Society of ChemoTherapy 16(4): 225-254
Spradling, P.; Nemtsova, E.; Aptekar, T.; Shulgina, M.; Rybka, L.; Wells, C.; Aquino, G.; Kluge, H.; Jakubowiak, W.; Binkin, N.; Kazeonny, B. 2002: Anti-tuberculosis drug resistance in community and prison patients, Orel Oblast, Russian Federation International Journal of Tuberculosis and Lung Disease: the Official Journal of the International Union Against Tuberculosis and Lung Disease 6(9): 757-762
Spradling, P.; Nemtsova, E.; Aptekar, T.; Shulgina, M.; Rybka, L.; Wells, C.; Aquino, G.; Kluge, H.; Jakubowiak, W.; Binkin, N.; Kazeonny, B. 2002: Anti-tuberculosis drug resistance in community and prison patients, Orel Oblast, Russian Federation International Journal of Tuberculosis and Lung Disease: the Official Journal of the International Union Against Tuberculosis and Lung Disease 6(9): 757-762
Pillay, D.; Albert, J.; Bertagnolio, S.; Boucher, C.; Brun-Vezinet, F.; Clotet, B.; Giaquinto, C.; Perno, C.F. 2013: Implications of HIV drug resistance on first- and second-line therapies in resource-limited settings: report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network Antiviral Therapy 18(6): 831-836
Wang, Q.-x.; Wang, X.; Chen, B.; Ma, Z.-l.; Liang, S.; Liao, L.-j.; Ma, M.-j.; Wei, D.-Y.; Qin, G.-m.; Ruan, Y.-h.; Shao, Y.-m.; Xing, H. 2011: Drug resistance and associated factors on HIV in Liangshan prefecture, Sichuan province Zhonghua Liu Xing Bing Xue Za Zhi 32(11): 1082-1086
Hamers, R.L.; Schuurman, R.; Sigaloff, K.C.E.; Wallis, C.L.; Kityo, C.; Siwale, M.; Mandaliya, K.; Ive, P.; Botes, M.E.; Wellington, M.; Osibogun, A.; Wit, F.W.; van Vugt, M.èl.; Stevens, W.S.; de Wit, T.F.R. 2012: Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study LANCET. Infectious Diseases 12(4): 307-317
McCue, J.D. 1985: Cefoxitin resistance in community-acquired gram-negative bacillary bacteremia. Associated clinical risk factors Archives of Internal Medicine 145(5): 834-836
Ely, B. 1979: Transfer of drug resistance factors to the dimorphic bacterium Caulobacter crescentus Genetics 91(3): 371-380
Choy, B.K.; McClarty, G.A.; Chan, A.K.; Thelander, L.; Wright, J.A. 1988: Molecular mechanisms of drug resistance involving ribonucleotide reductase: hydroxyurea resistance in a series of clonally related mouse cell lines selected in the presence of increasing drug concentrations Cancer Research 48(8): 2029-2035
Bertagnolio, S.; Rodriguez-Diaz, R.A.; Fuentes-Romero, L.L.; Bennett, D.E.; Viveros-Rogel, M.; Hart, S.; Pilon, R.; Sandstrom, P.; Soto-Ramirez, L.E. 2012: Transmitted HIV drug resistance among drug-naive subjects recently infected with HIV in Mexico City: a World Health Organization survey to classify resistance and to field test two alternative patient enrollment methods Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 54(Suppl 4): S328-S333
Yoshiyama, M. 1988: Bioenergy recovery phenomenon in the myocardium following ischemia and factors contributing to the recovery studied by 31P magnetic resonance spectroscopy Osaka City Medical Journal 34(2): 201-221
Jordan, M.R.; Bennett, D.E.; Bertagnolio, S.; Gilks, C.F.; Sutherland, D. 2008: World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites Antiviral Therapy 13 Suppl. 2: 15-23
Fujino, T.; Hasegawa, N.; Satou, R.; Komatsu, H.; Kawada, K. 1998: Attributable factors to the emergence of multidrug-resistant Mycobacterium tuberculosis based on the observation of consecutive drug resistance test results Kekkaku: 73(7): 471-476
Zhao, J.; Liu, J. 2015: The drug resistance mutation detection and relevant factors analysis of HBV P region in chronic hepatitis B patients in Weifang City, Shandong Province Bing du Xue Bao 31(1): 14-17
Wang, F. 2006: To enhance the research of antibiotic resistance and infection caused by drug-resistance bacteria Zhonghua Yi Xue Za Zhi 86(9): 579-580
Rabinovich, S.A. 1976: Drug resistance in malaria parasites. 1. The nature of resistance, its distribution and epidemiological implications (review of the literature) Meditsinskaia Parazitologiia i Parazitarnye Bolezni 45(4): 464-477
Danks, M.K.; Yalowich, J.C.; Beck, W.T. 1987: Atypical multiple drug resistance in a human leukemic cell line selected for resistance to teniposide (VM-26) Cancer Research 47(5): 1297-1301
Harada, Y.; Kitahara, Y.; Ninomiya, H.; Harada, S.; Takamoto, M.; Ishibashi, T. 1994: A study on drug resistance of newly admitted pulmonary tuberculosis patients with special reference to the resistance to SM, INH, EB and RFP Kekkaku: 69(12): 751-757
Baba, H. 1994: Studies on the problems of resistance to antituberculous drugs. II--1. Clinically applicable criteria of drug-resistance to rifampicin Kekkaku: 69(6): 387-396